intratumoral immunotherapy
Jump to navigation
Jump to search
Introduction
intratumoral immunotherapy for solid tumor
Indications
- talimogene laherparepvec (Imlygic) for unresectable cutaneous melanoma
More general terms
References
- ↑ Goldmacher GV, Khilnani AD, Andtbacka RHI et al Response Criteria for Intratumoral Immunotherapy in Solid Tumors: itRECIST. J Clin Oncol 2020 Aug 10;38(23):2667-2676 PMID: https://www.ncbi.nlm.nih.gov/pubmed/32552274 PMCID: PMC7402995 Free PMC article https://ascopubs.org/doi/full/10.1200/JCO.19.02985